Published • loading... • Updated
Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
Summary by TechCrunch
3 Articles
3 Articles
TechCrunchReposted by 
BizToc
BizTocScience Corporation implants its vision-restoring chip in its first Stargardt disease patient
Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
·San Francisco, United States
Read Full Article
A patient with Stargardt’s disease received the retinal implant PRIMA in a trial in Australia and, during his first rehabilitation sessions, he went from recognizing a letter to reading a word. Science Corporation presents progress as part of its commitment to brain-computer interfaces, although the device still offers a reduced, black-and-white visual field.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
